High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies
Nom du journal : EBioMedicine
Année : 2020
Volume : 62
Page de départ : 103131